Study	Year	Country	Diseases	Case Number	Stage	Sample	Assay	Cut-off value	HR	Follow-up (months)	Type of miR-17 detection
Chen et al	2012	China	HCC	120	I-IV	Tissue	qRT-PCR	Median	RR	46	miR-17–5 p
Qun et al	2013	China	Lung Cancer	221	I-IV	Tissue	qRT-PCR	Median	Given	50	miR-17
Li et al	2014	China	Osteosarcoma	117	I-III	Tissue	qRT-PCR	Median	Given	44	miR-17
Lu et al	2012	China	Glioma	108	I-IV	Tissue	qRT-PCR	Mean	RR	60	miR-17
Xi et al	2015	China	T-cell lymphoblastic lymphoma	57	III, IV	Tissue	qRT-PCR	Median	Given	Up to 13 years	miR-17
Yu et al	2012	China	Colon Cancer	48	I-IV	Tissue	qRT-PCR	Median	Given	5–66	miR-17
Manuel et al	2011	Spain	Gastrointestinal Cancer	38	I-IV	Tissue	qRT-PCR	Mean	Given	38	miR-17
Robaina et al	2016	Brazil	Burkitt lymphoma	41	I-IV	Tissue	qRT-PCR	Median	Given	69	miR-17
Xu et al	2014	China	Esophageal Squamous Cell Carcinoma	105	I-IV	Tissue	qRT-PCR	Mean	Given	52	miR-17
Jun et al	2010	Japan	Pancreatic Cancer	80	I-IV	Tissue	qRT-PCR	Median	Given	60	miR-17–5 p
Wang et al	2011	China	Gastric Cancer	65	I-IV	Serum	qRT-PCR	Median	Given	36	miR-17–5 p
Zheng et al	2013	China	HCC	96	I-IV	Serum	qRT-PCR	Median	Given	NG	miR-17–5 p